Found some information on their prostate cancer drug presented at ASCO in 2011. They had 8 patients in their phase I trial and the median survial was 25 months. This was just to identify a dose and find toxicities so I wouldn't read too much into it. Just found it interesting because it was very difficult to find and haven't heard much about their prostate drug.